Retinal Toxicity from Chronic Hydroxychloroquine use in Kenya.
Ann Afr Med
; 21(3): 301-304, 2022.
Article
in English
| MEDLINE | ID: covidwho-2055682
ABSTRACT
Irreversible visual loss due to retinal toxicity is one of the side effects of hydroxychloroquine (HCQ) therapy. The recent outbreak of the novel coronavirus-19 (COVID 19) has seen HCQ proposed as a possible treatment and prophylactic drug, leading to its increased use. Many are unaware of its ocular side effects. We describe a case of HCQ-induced retinopathy in a 46-year-old female who was referred by a rheumatologist for routine eye review.
Résumé La perte de vision irréversible secondaire à la toxicité rétinienne est l'un des effets indésirables du traitement à l'hydroxychloroquine (HCQ). Nous décrivons un cas d'une patiente âgée de 46 ans, présentant une rétinopathie secondaire au traitement à l'HCQ référée par un Rhumathologue pour un examen ophtalmique. Mots-clés Hydroxychloroquine, rétine toxicité rétinienne, rétinopathie.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Retinal Diseases
/
Antirheumatic Agents
/
COVID-19 Drug Treatment
Type of study:
Case report
/
Observational study
Limits:
Female
/
Humans
/
Middle aged
Country/Region as subject:
Africa
Language:
English
Journal:
Ann Afr Med
Year:
2022
Document Type:
Article
Affiliation country:
Aam.aam_118_21
Similar
MEDLINE
...
LILACS
LIS